A series of novel compounds (4a, 4b, 4c, and 4d) were designed, synthesized and characterized for their anticancer and anti-inflammatory activities. The anticancer efficacy was evaluated in vitro against MCF7 and ZR-75-1 human breast cancer cell lines, using parameters such as LC50, TGI, and GI50. Among the compounds,...
P. Dube, Yogita B. Thombare, S. Tambe et al.· Indian drugs· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.